Complementary effect of spirulina in the treatment of opioid patients under methadone maintenance treatment
Phase 2
Recruiting
- Conditions
- Addiction.Other psychoactive substance related disorders
- Registration Number
- IRCT20231101059923N2
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Consent and informed willingness to participate in research
Positive methadone urine test
Using methadone for at least one year
Married men in the age range of 30-50 years
Exclusion Criteria
Suffering from chronic physical diseases including phenyl ketonuria, autoimmune diseases, AIDS, hepatitis, liver and kidney disorders, cardiovascular disorders, etc. at the time of entering the treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mental health. Timepoint: At the beginning of the study and the twelfth week of the study. Method of measurement: Depression‚ Anxiety‚ Stress Scale (DASS21).;Sexual function. Timepoint: At the beginning of the study and the twelfth week of the study. Method of measurement: International Index of Erectile Function (IIEF).
- Secondary Outcome Measures
Name Time Method Craving. Timepoint: At the beginning of the study and the twelfth week of the study. Method of measurement: Desire for Drug Questionnaire (DDQ craving).;Cognitive function. Timepoint: At the beginning of the study and the twelfth week of the study. Method of measurement: Cattell–Horn–Carroll (CHC) approach.